Cargando…
Policy options to deal with high-cost medicines – survey with European policy-makers
Autores principales: | Zimmermann, Nina, Vogler, Sabine, Bak Pedersen, Hanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603735/ http://dx.doi.org/10.1186/2052-3211-8-S1-P8 |
Ejemplares similares
-
Pharmaceutical policies in European countries in response to the global financial crisis
por: Vogler, Sabine, et al.
Publicado: (2011) -
Reimbursement measures in European countries – findings of a bibliometric literature review
por: Vogler, Sabine, et al.
Publicado: (2015) -
Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015) -
Socioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities
por: Vogler, Sabine, et al.
Publicado: (2015) -
Incremental Cost-effectiveness Thresholds for Policy Decision-makers
por: Al-Zakwani, Ibrahim
Publicado: (2022)